Etaracizumab (Anti-Integrin aVb3 (ITGAV & ITGB3)) | Integrin

Etaracizumab (Anti-Integrin aVb3 (ITGAV & ITGB3)) is an IgG1 monoclonal antibody targeting αvβ3 integrin. It inhibits angiogenesis and melanoma tumor growth and can be used to research anticancer. MW :144.18 KD.

Purity & Quality Control

Batch: A299101 Purity: 99% Protein concentration: 16.91mg/ml Endotoxin Level: ＜1EU/mg

99

Choose Selective Integrin Inhibitors

Biological Activity

Description	Etaracizumab (Anti-Integrin aVb3 (ITGAV & ITGB3)) is an IgG1 monoclonal antibody targeting αvβ3 integrin. It inhibits angiogenesis and melanoma tumor growth and can be used to research anticancer. MW :144.18 KD.

References
[1] Hersey P, et al. Cancer. 2010 Mar 15;116(6):1526-34.

References

[1] Hersey P, et al. Cancer. 2010 Mar 15;116(6):1526-34.

Product Details

CAS No.	892553-42-3
Molecular Weight	144.18
Isotype	Human IgG1
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field